Clinical Practice Alert: Chlamydia and Gonorrhea Screening and Treatment

Clinical Practice Alert: Chlamydia and Gonorrhea Screening and Treatment

Key recommendations for chlamydia and gonorrhea screening and treatment for individuals assigned female at birth.

FamilyPACT logo

Clinical Practice Alert: Cervical Cancer Screening

Clinical Practice Alert: Cervical Cancer Screening

Key recommendations for cervical cancer screening from the American College of Obstetricians and Gynecologists (ACOG) and the multidisciplinary partnership of the American Cancer Society, the American Society for Colposcopy and Cervical Pathology (ASCCP), and the American Society for Clinical Pathology.

Providing Family PACT Services During COVID-19 Part 2: Understanding Benefit Changes

September 17, 2020

The ongoing COVID-19 public health emergency has caused a shift from providing exclusively in-person services to a combination of remote and in-person visits, referred to as “hybrid visits”. This webinar will provide an update of how Family PACT services (client encounters) have changed since March, 2020.

The following topics are covered in detail:

  • Medi-Cal/Family PACT policy for telephonic-only remote visits.
  • A series of case studies including contraceptive visits, evaluation of genital tract infections, well person visits, and a colposcopy visit, with an emphasis on coding and billing Family PACT.

Presenters:

Resources

Implementing the 2019 ASCCP Risk-Based Management Guidelines for Abnormal Cervical Cancer Screening Tests in Your Practice

July 23, 2020

The long-awaited new ASCCP Management Guideline App is now available, as well as the print version of the 2019 Guidelines. The new guidelines are streamlined for ease of use and can be significantly more individualized than the 2012 guidance by integrating information about an individual’s previous screening test and biopsy results, and personal factors such as age and immunosuppression. The guidelines now provide recommended follow up for all 3 available cervical screening strategies.

The following topics are covered in detail:

  • The rationale used in developing the Guidelines
  • How various abnormalities should be managed
  • Interactive demonstrations of how to use the app
  • Specific considerations for the application of Family PACT benefits, including coding and billing

Learning objectives: At the end of this session, the learner will be able to:

  1. Describe the risk-based paradigm for managing abnormal cervical cancer screening test results.
  2. Explain how risk-thresholds guide the clinical actions of immediate treatment, colposcopy, and short-interval follow up.
  3. Demonstrate use of the ASCCP app to apply the new guidelines to patient care.

Presenters:

Resources

Providing Family PACT Services During COVID-19 Part 1: Clinical Considerations

May 8, 2020

Since March 2020, most providers of family planning services in California have shifted patient care from in-person visits to remote visits. This webinar will be conducted in a “frequently asked questions” format, focusing on the adaptations that clinicians should make in order to successfully provide family planning care remotely during the public health emergency and afterward.

The following topics are covered in detail:

  • Subjects will include the role of blood pressure measurement before prescribing combined hormonal contraception
  • The use of injectable birth control subcutaneous depot medroxyprogesterone acetate (DMPA-SQ)
  • Syndromic treatment of sexually transmitted infections
  • Pregnancy testing without a clinic visit.
  • Recently enacted Family PACT and Medi-Cal policies regarding telehealth visits and remote enrollment of clients into the Family PACT program.

Presenters:

Resources

Clinical Practice Alert: Cervical Cancer Screening and Emergency Contraception

March 24, 2020

This webinar features two new Family PACT Clinical Practice Alerts.

Cervical Cancer Screening

Topics in this portion of the webinar will include benefits through Family PACT that have been expanded to include high-risk HPV-alone screening, use of this test, alternative cervical cancer screening options, and new guidelines regarding cervical cancer screening for females who are HIV positive or who are immunocompromised.

Emergency Contraception

Topics in this portion of the webinar will include the relationship between body weight and emergency contraception failure rates, when oral contraceptives can be started with females who have used ulipristal acetate, options for accessing emergency contraceptive pills and the use of the copper IUD as emergency contraception.

Presenters:

Resources:

Clinical Practice Alert: Chlamydia and Gonorrhea Screening and Treatment

June 20, 2019

Rates of sexually-transmitted diseases (STDs) such as chlamydia trachomatis (CT) and gonorrhea (GC) have reached an all-time high. In the U.S., California leads the nation in reported cases of these STDs. Because persons with CT and GC are often asymptomatic, screening is essential for the early detection and treatment that can prevent reproductive complications including pelvic inflammatory disease (PID), tubal infertility, ectopic pregnancy, and chronic pelvic pain in females and epididymitis in males.

This webinar covers current clinical guidelines for routine and targeted screening, treatment, follow-up, and prevention of CT and GC.

Learning objectives:

  1. Understand current guidelines for screening for CT and GC among sexually active women and men
  2. List the indications for anorectal and oropharyngeal CT/GC screening
  3. Explain when test-of-cure is indicated
  4. Identify the proper ICD-10 codes for lab requests and billing information

Presenters:

Resources:

Pain Management: Tips, Tricks, and Evidence

February 5, 2019

Patients often experience varying levels of pain or discomfort from procedures performed during family planning visits. The purpose of this webinar is to provide clinicians with evidenced-based tips, tricks, and strategies on how to prevent and minimize pain during family planning procedures.

The webinar focuses on the most commonly performed family planning procedures such as: IUD insertion/removal, implant insertion/removal, colposcopy, biopsy, and vulvar biopsy. Less common procedures for non-gynecologists such as LEEP, cryo, and procedures not covered by the Family PACT Program are not discussed.

The following topics are covered in detail:

  • Three components and factors associated with procedure pain and strategies to alleviate discomfort
  • Four examples of trauma-informed care practices for family planning clients
  • Three examples of ways to use patient-centered language during pelvic exams
  • Considerations for administering and providing the appropriate level of local anesthetic
  • Pain management for family planning procedures

Presenter:

Prevention and Management of IUD Complications

October 4, 2018

The purpose of the webinar is to provide clinicians who are doing IUD placements with advanced skills to prevent and manage the uncommon complications that can occur with the placement and use of IUDs. It consists of case studies that detail the management of difficult IUD placements owing to cervical stenoisis, morbid obesity, and vasovagal syncope. Management of IUD complications, including uterine perforation, tenaculum site injuries, and post-IUD placement infection will be discussed. The work-up and management of the patient with a “missing” IUD string, including variants of malpositioned IUDs and intrauterine pregnancy with an IUD in place, are explained as well.

The following topics are covered in detail:

  • Maneuvers that can be performed to improve the likelihood of successful placement in morbidly obese patients
  • Techniques to avert vaso-vagal episodes and 4 sequential steps in the management of a vaso-vagal syncope
  • The most common predisposing factors for uterine perforation with IUD placement
  • Causes of a “missing” IUD string and how each is managed
  • Management of post-IUD placement pelvic inflammatory disease

Presenter:

Resources:

S4 E4: When People Have or Are Denied Abortions: The Turnaway Study with Diana Greene Foster

S4 E4: When People Have or Are Denied Abortions: The Turnaway Study with Diana Greene Foster

""

Welcome to our mini-series on Reproductive Justice and Family Planning! Diana Greene Foster, PhD, author of The Turnaway Study: Ten Years, a Thousand Women, and the Consequences of Having – or Being Denied – an Abortion, sits down with host Tammy Kremer to advocate for reproductive justice and bodily autonomy. She explains that the Turnaway Study found that, “When people are making the decision about what to do with an unexpected pregnancy and they decide on abortion, all the reasons they give us are exactly those outcomes that we see for people who are denied an abortion.” She envisions a world in which “everyone is an equal partner in sex, in childbearing, in contraception, in pregnancy decision-making.” 

Download the transcript of this episode.

Follow Diana Greene Foster on Twitter.

Resources: 

The Turnaway Study: Ten Years, a Thousand Women, and the Consequences of Having—or Being Denied—an Abortion 

Global Turnaway Study 

ANSIRH: Advancing New Standards in Reproductive Care 

Bixby Center for Global Reproductive Health  

Plan C Pills 

“Black Women’s Lived Experiences of Abortion” 

Girlx Lab

CAPTC-Related Training and Resources:  

S3 E9: Abortion and Reproductive Justice Across State Lines    

S2 E2: Speaking Frankly: Supporting Youths’ Choice to Parent with Dr. Aisha May 

Reproductive and Sexual Health Considerations for Trans and Non-Binary People 

Turn on notifications to never miss an episode of Coming Together for Sexual Health.

Follow Coming Together for Sexual Health on Instagram and Twitter.

Diana Greene Foster is a professor at the University of California, San Francisco, in the Department of Obstetrics, Gynecology, and Reproductive Sciences and a researcher at Advancing New Standards in Reproductive Health. She is the principal investigator of the Turnaway Study in the United States and Nepal, a nationwide longitudinal prospective study of the health and well-being of women who seek abortion including both women who do and do not receive abortion.